Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
XORTX Therapeutics Inc (DE:ANUA)
FRANKFURT:ANUA
XORTX Therapeutics Inc (ANUA) Stock Price & Analysis
2 Followers
ANUA Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.30 - €7.65
Previous Close€2.25
Volume0.00
Average Volume (3M)2.49K
Market Cap
€4.49M
Enterprise Value€350.20K
Total Cash (Recent Filing)C$6.16M
Total Debt (Recent Filing)C$45.19K
Price to Earnings (P/E)N/A
Beta-0.66
Next Earnings
May 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding17,989,687
10 Day Avg. Volume880
30 Day Avg. Volume2,492
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
XORTX Therapeutics Inc News
PremiumCompany Announcements
XORTX Therapeutics Revises Warrant TermsPremiumCompany Announcements
XORTX Therapeutics Adjusts Warrant Exercise Price
PremiumCompany Announcements
XORTX’s Breakthrough Study on Kidney Disease
PremiumCompany Announcements
XORTX’s Research Offers New Hope for ADPKD
PremiumCompany Announcements
XORTX Therapeutics Boosts Board with Biotech ProANUA FAQ
What was XORTX Therapeutics Inc’s price range in the past 12 months?
XORTX Therapeutics Inc lowest stock price was €0.30 and its highest was €7.65 in the past 12 months.
What is XORTX Therapeutics Inc’s market cap?
Currently, no data Available
When is XORTX Therapeutics Inc’s upcoming earnings report date?
XORTX Therapeutics Inc’s upcoming earnings report date is May 29, 2024 which is in 14 days.
How were XORTX Therapeutics Inc’s earnings last quarter?
XORTX Therapeutics Inc released its earnings results on Apr 02, 2024. The company reported €1.269 earnings per share for the quarter, beating the consensus estimate of -€0.411 by €1.68.
Is XORTX Therapeutics Inc overvalued?
According to Wall Street analysts XORTX Therapeutics Inc’s price is currently Overvalued.
Does XORTX Therapeutics Inc pay dividends?
XORTX Therapeutics Inc does not currently pay dividends.
What is XORTX Therapeutics Inc’s EPS estimate?
XORTX Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XORTX Therapeutics Inc have?
Currently, no data Available
What happened to XORTX Therapeutics Inc’s price movement after its last earnings report?
XORTX Therapeutics Inc reported an EPS of €1.269 in its last earnings report, beating expectations of -€0.411. Following the earnings report the stock price went down -1.608%.
Which hedge fund is a major shareholder of XORTX Therapeutics Inc?
Currently, no hedge funds are holding shares in DE:ANUA
---
XORTX Therapeutics Inc Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:ANUA Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth C$39.7K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.16%
12-Months-Change
Fundamentals
Return on Equity
-36.72%
Trailing 12-Months
Asset Growth
-56.96%
Trailing 12-Months
Company Description
XORTX Therapeutics Inc
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.
---
ANUA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ANUA
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-33.40%
reiterated a buy rating 4 months ago
Copying James Molloy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -33.40% per trade.
---